Pharmacovigilance 2010
Offering our customers the knowledge and connections for a profitable business
  • Gopal Pande Center for Cellular & Molecular Biology

  • Sanjay Zodpey Public Health Foundation of India

  • Krathish Bopanna Acunova

  • Arunima Sen MMS Holdings Incorporation

  • Parminder Kaur RegPak BioPharma Consulting

  • Arun Bhatt Clininvent Research

  • Mahesh Malneedi Macro Care

  • Vishwas Sovani TCS

  • Dipti Kadam DBMS Consulting

  • Siddarth S. Chachad Cipla

  • Arani Chatterjee Panacea Biotec

  • Milind Antani Nishith Desai Associates

  • Subbaraju Sagi Oracle Life Sciences

  • Deven Parmar MD Wockhardt

  • Prashanth BSB Cipla

  • Bhaswat S. Chakraborty Cadila Pharmaceuticals

  • Simrat Sohal Eli Lilly

  • Viraj Rajadhyaksha Pfizer

  • Veena Rajan AstraZeneca

  • Zoher Sihorwala Dr. Reddy’s

  • Akhilesh Sharma Dr. Reddy’s

21 & 22, January 2010, Hotel ITC Maratha, Mumbai, India

"Overseeing risks and Optimizing drug safety in todays pharma market"

Sponsors & Exhibitors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Conference Info
  • Day 1
  • Day 2
  • Speakers
  • Sponsors
  • Partners
  • Sponsorship Opportunity
  • Delegates
  • Pricing
  • Venue
  • Testimonials
  • Presentations
  • Gallery


Pharmacovigilance is the science and actions relating unfolding to detection, evaluation, understanding and prevention of adverse effects or any other likely medicine related problems. The main aim of pharmacovigilance is to improve patient care and safety in relation to use of medicines and other interventions. Despite all the benefits of medicines in disease management, there continues to be problems related to adverse reactions which are important cause for morbidity and mortality in many countries. Significant harm to even a few patients, not only destroys the credibility of the medicine, the patients also tend to loose trust on the the health system. A good Pharmacovigilance system will identify the risks in the shortest possible time, so that any  harm can be avoided or minimized. The most frightening thought for any pharma company is the prospect of a drug withdrawal. As the costs associated with product withdrawals escalate the importance of pharmacovigilance increases.

India has more than half a million qualified Doctors and15,000 hospitals having bed strength of 6,24,000. It is the fourth largest producer of pharmaceuticals in the world. It is emerging as an important Clinical trial hub in the world. Many new drugs are being introduced in our country. Therefore, there is a need for a vibrant pharmacovigilance system in the country to protect the population from the potential harm that may be caused by some of these new drugs. The most effective way to avoid a safety crisis is to implement a progressive pharmacovigilance strategy now.

Pharmacovigilance 2010 conference will discuss the on-going pressing concerns faced in drug safety, addressing the risks, timeline and budget constraints.  This conference brings together top pharmaceutical, biotechnology and regulatory representatives in a forum that addresses the key issues of the industry. The in-depth program covers discussions on the detection, analysis and prevention of adverse drug reactions with case studies and sharing of industry experiences and best practices. Understand and learn the latest insights, tools and knowledge to ensure that you and your firm catch up with the current and future market. Analyze along with the market leaders, the latest developments in pharmacovigilance which would shape your organization-wide risk management strategy.


  • Reviewing the best revenue generating models in suitable for current and future PV market.
  • Grabbing the opportunity: learning about the challenges & complexities in the role
  • Best practices, service offerings & deployment
  • Global marketing strategies in order to engage with regulatory centres of excellence on pharmacovigilance and to understand their perspectives on best practice &  future trends
  • Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
  • Exploiting the role of electronic data standards and controlled vocabularies in pharmacovigilance
  • Positioning yourself in light of new market entries
  • Analyzing the worldwide trends in PV & lessons for India.
  • Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
  • Updating yourself with respect to terms of legislation, policies, systems, technology, communication strategies and best practice in PV
  • Dwell ahead of regulatory developments & improving your risk management strategies in a cost effective way 


VP’s, Directors, Heads and Managers of:

  • Pharmacovigilance Strategy
  • Drug Safety/Risk Management
  • Information and Clinical Data Management
  • Clinical Research
  • Research & Development and Product Safety/Assurance Assessment
  • Patient Safety and Outcomes Research and Data Analysis
  • Epidemiology project management
  • Regulatory Affairs and Compliance
  • Sales & Marketing


Pharmacovigilance 2010 - “Overseeing risks & Optimizing drug safety in today’s pharma market”

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.















08:45 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.

09:30 – Chair’s opening remarks

Arani Chatterjee, Vice President, Clinical Research Panacea Biotec

09:40 – Keynote Address: Latest developments in pharmacovigilance - Changing EU, US & Rest of the world (RoW) requirements

Akhilesh Sharma, Vice President & Global Head Clinical Management & Global Pharmacovigilance, Dr. Reddy’s

10:20 – Enabling risk management: from safety signal to risk/benefit management

Subbaraju Sagi, Senior Solutions Consultant, Oracle Life Sciences         

11:00 – Morning coffee & Discussion

11:20 - Pre-approval Periodic safety reporting using DSUR and Post Marketing reporting using PSUR – Understanding the essentials

Sanish Davis, Clinical Research Manager, PGRD, Pfizer

12:00– Panel discussion: Challenges in upcoming markets

  • What are the successful strategies to face the future challenges in pharmacovigilance
  • Analyzing the changing business environment
  • Evaluating where are the opportunities and threats in emerging markets


Gopal Pande, Scientist, Center for Cellular & Molecular Biology


Arunima Sen, Manager Medical Team, MMS Holdings Incorporation

Veena Rajan, Head - Patient Safety, AstraZeneca

12:30 – Emerging technologies & Strategies in drug safety evaluation

Mahesh Malneedi, President, Macro Care

13:00 - Networking luncheon

14:10 - Signal detection with Oracle product 

Dipti Kadam, Consultant - Clinical Technology & System, DBMS Consulting

14:40 – Growth of pharmacovigilance systems - India

  • Benefits of developing PV in India
  • Analyzing the current and the future of PV in India
  • Demand for efficient PV by middle class Indians

Deven Parmar MD, Vice President - Clinical Research & Pharmacovigilaance, Wockhardt

15:20 – Afternoon tea

15:40 –  Role of Therapeutic alliance in PV

16:10 - Panel Discussion - Regulator’s perspective

  • Pharmacovigilance from the Regulator’s Perspective – Latest Updates
  • Understanding how companies can work more successfully with regulators.
  • What can the regulators do to help industry?
  • Determining the best strategy to secure approval.
  • An overview of the Global Regulatory Safety Information Database


Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates


Zoher Sihorwala, Vice - President Global Regulatory Affairs, Dr. Reddy's

Arun Bhatt, President, Clininvent Research

Parminder Kaur, Managing Director, RegPak BioPharma Consulting

16:50 – Chairperson’s closing remarks and End of Conference

17:20 - Networking Drinks - Take your discussions further & build new relationships in a relaxed & informal setting.

08:45 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.

09:30 – Morning Chair’s opening remarks

09:40 – Data mining & signal detection in Pharmacovigilance

Bhaswat S. Chakraborty, Senio VP, R&D, Cadila Pharmaceuticals

10:20 – Pharmacovigilance in focus

  • Economic impact of ADR
  • Thalidomide status through PV
  • Real lessons from Vioxx
  • Best selling drugs & adv through PV for these drugs
  • Practical problems & Challenges in PV
  • Penalties on non-complaint to PV

Prashanth BSB, Medical & Safety expert (Regulatory affairs), Cipla

11:00 – Morning coffee & Discussion

11:20 – Panel Discussion - Working towards patient subject safety from early development

Advanced Pharmacology Techniques and Methodologies to Improve Safety

Putting the patient first – The importance of developing a comprehensive post-marketing surveillance strategy



S. K. Kulkarni, Emeritus Scientist & Emeritus Professor of Pharmacology 

Siddarth S. Chachad, Medical & Safety Expert (Regulatory Expert), Cipla

12:00 – Challenges in local regulations for PV

Simrat Sohal, Head - Pharmacovigilance, Eli Lilly

12:40 – Networking luncheon

13:50 – Afternoon Chair's opening remarks

Sanjay Zodpey, Director, Public Health Foundation of India 

14:00 – Pharmacovigilance data management services: Challenges & Opportunities

Speaker TBC, Oracle Life Sciences

14:40 – Challenges in Pharmacovigilance: Different Sponsors, Same Drug

  • What are current “best practices” in this challenging area?
  • How can “continuous safety monitoring” be achieved?
  • What are issues in signal detection across sponsors and trans-nationally?
  • Best methods for pharmacovigilance, signal detection, risk management in this setting

Vishwas Sovani, MD, Vice President, Pharma Delivery, TCS

15:20 – Afternoon tea

15:40 – Risk management -

  • Lessons to be learned from extensive drug safety research
  • Cutting-edge risk management, how to prepare for the  worst
  • Managing developments and adapting to changing information
  • Constant improvement in risk management strategies
  • Developing and maintaining exemplary drug safety standards

16:20 – Panel Discussion – SWOT analysis

Strength, Weakness, Opportunities & Threats of Pharmacovigilance in India (Overall review of this Pharmacovigilance 2010 conference)


Sanjay Zodpey, Director, Public Health Foundation of India


Krathish Bopanna, Senior Vice President, Acunova

Viraj Rajadhyaksha, Senior manager, Operations, Planning & Management Clinical Research, Pfizer

17:00 – Chairperson’s closing remarks and End of Conference

Gopal Pande


Center for Cellular & Molecular Biology

Sanjay Zodpey


Public Health Foundation of India

Krathish Bopanna

Senior Vice President


Arunima Sen

Manager Medical Team

MMS Holdings Incorporation

Parminder Kaur

Managing Director

RegPak BioPharma Consulting

Arun Bhatt


Clininvent Research

Mahesh Malneedi


Macro Care

Vishwas Sovani

MD, VP, Pharma Delivery


Dipti Kadam

Consultant - Clinical technology & System

DBMS Consulting

Siddarth S. Chachad

Medical & Safety Expert (Regulatory Affairs)


Arani Chatterjee

Vice President, Clinical Research

Panacea Biotec

Milind Antani

Head-Pharma LifeSciences group

Nishith Desai Associates

Subbaraju Sagi

Senior Solutions Consultant

Oracle Life Sciences

Deven Parmar MD

Vice President - Clinical Research & Pharmacovigilaance


Prashanth BSB

Medical & Safety expert (Regulatory Affairs)


Bhaswat S. Chakraborty

Senior VP, R&D

Cadila Pharmaceuticals

Simrat Sohal

Head - Pharmacovigilance

Eli Lilly

Viraj Rajadhyaksha

Senior Manager, Operations, Planning & Management Clinical Research


Veena Rajan

Head - Patient Safety


Zoher Sihorwala

Vice President Global Regulatory Affairs

Dr. Reddy’s

Akhilesh Sharma

Vice President & Global Head Clinical Management & Global Pharmacovigilance

Dr. Reddy’s


Virtue insight

Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.

Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.


Oracle Health Sciences



DBMS Consulting is specialized in Implementation and Deployment of Oracle Health Sciences (OHS) Applications. DBMS Consulting has performed over 100 installations for its clients globally. The clients include Global Pharmaceuticals, CROs, Biotechs, Medical Device Companies, Academic Institutions and Government Institutions throughout the U.S., Europe and Asia.

DBMS has been awarded with Oracle’s prestigious Partner of the year award for its life sciences business in India (2008). DBMS offers implementation support for OLS suite, Siebel - Clinical Trial management System and its integration with other Oracle Applications (like OC/TMS and Oracle Financials/e-business).

DBMS Consulting has recently received Honorable Mention in Life Sciences & Health Care Industry Solution Category at “Oracle Open World 2009 North America Alliances and Channels Titan Award Ceremony”



Tata Consultancy Services is an IT services, business solutions and outsourcing organization that delivers real results to global businesses, ensuring a level of certainty no other firm can match. TCS offers a consulting-led, integrated portfolio of IT and IT-enabled services delivered through its unique Global Network Delivery Model, recognized as the benchmark of excellence.  TCS BPO specializes in Industry specific services and leverages its IT heritage to offer transformational services including Platform BPO.

A part of the Tata Group, India’s largest industrial conglomerate, TCS has over 140,000 of the world's best trained IT consultants in 42 countries. The company generated consolidated revenues of US $6 billion for fiscal year ended 31 March 2009. For the H1 FY 2010 quarter, BPO revenues were close to 12%of TCS revenues.  TCS is listed on the National Stock Exchange and Bombay Stock Exchange in India. For more information, visit


Macro Care


Until ROI

Until ROI is a Metrics Based Marketing Strategy and Execution company. We work with clients in establishing the right marketing mix, reaching out to the right opportunities, coupled with high quality execution. With a solid understanding of media, both Online and Offline, we empower our clients to take confident marketing decisions, backed by strong ROI numbers.


Tim Tec

Provenance Research

Provenance Research provides comprehensive end-to-end contract services to the pharmaceutical, biotechnology and medical device industries. We offer a range of services to our clients throughout the lifecycle of the product from clinical development to marketing. These services include Conceptualization of Trial design, Clinical study documents preparation, Clinical research operations, Pharmacovigilance, Regulatory services, Medical writing, and Medical marketing support services including promotional medical literatures, web content development, CME, e-marketing, and event management.

An educational website on Pharmacovigilance, aimed at creating awareness about the magnitude of drug safety problem in India and to convince health care professionals about the importance of reporting adverse drug reactions. The main objective of the site is to provide information about India’s national pharmacovigilance programme to healthcare professionals.

" is the world leading website designed specifically for pharmaceutical, clinical and biotechnology professionals. brings up-to-date information on pharmaceutical patents, FDA, news, jobs and Buyer's Guide to our visitors.  It was created and is maintained by pharmaceutical and biotechnology professionals.  Visit and discover for yourself why it is so popular among professionals."


ThePharmYard is developing into a valuable service providing instant access to expert information, guidance and analysis for individuals working within, or intending to work within, the medical and pharmaceutical industries. The service is free to access by all users.

ThePharmYard is an initiative from NetworkPharma Ltd, a company which has been established by our Managing Director, Peter Llewellyn, to provide first-rate business information services for the medical and pharmaceutical industries, focusing on delivery via Internet and new media technologies.

A particular feature of the underlying NetworkPharma platform is the high level of personal confidentiality and privacy provided to our users. This is of paramount importance when working within a sensitive, high technology environment such as the medical and pharmaceutical industries. Users will find a number of security features in place and, for instance, an important fundamental principle is that email addresses and other personal details of our individual users are never made public nor sold to third parties.

We are keen to hear from anyone with ideas, comments and feedback which will help us develop faster and more effectively to deliver the services that our community members really want and really appreciate.

Designed for the generic industry

An intelligent sourcing and acquisition tools based on a deep understanding of industry requirements.

Looking for generic or biosimilar registration dossiers?

The largest qualified database of available and in-development generic products; services that will proactively work on your behalf, providing the knowledge and expertise to help your inlicensing activities.

Have dossiers and new product developments?

We offer powerful promotional opportunities to launch new products or increase your company profile to the people who matter to your business. Major players and local companies, worldwide.

PharmaVOICE magazine, reaching more than 17,500 U.S.-based life-sciences executives, is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE, and its supporting VIEW publications, provide readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts. Additionally, provides a comprehensive directory of products, services, and solutions for the life-sciences industry.

Partnering with Virtue Insight means more than making the right contacts. It means being an insider. It means being connected to the right people with the right level of influence, and it means you are allied with a globally respected organization and leaders in the industry.?

Sponsorship, exhibiting and advertising packages are designed to provide a solid platform to help you stand out and make an impact. Our programs allow you to achieve your marketing goals and deliver a maximum return on your investment. We have developed convenient and customizable packages to help your organization meet its objectives and reach your target market.

Why Sponsor / Exhibit:

PROFIT: To Maximize
MARKET SHARE: Defending and Increasing Market Share
COMPETITION: To attach and defend against competition


  • Generating sales leads
  • Build brand image
  • Maintaining customer relations
  • Consolidating business relationships
  • Accessing new and emerging markets
  • Obtaining technical knowledge
  • Leverages the events extensive marketing campaign to add value to your organisations marketing strategy and budget leading up to the event
  • Live product demonstration to test market responses
  • Facilitating quick market penetration
  • Reach important targeted commercial prospects face to face in a social, relaxed environment. The ideal platform to build strong business friendships Strengthen your market position

Our conferences offer not only a unique combination of benefits (as listed above) to enable the sponsor/exhibitor to communicate the message but also a major opportunity that other forms of selling or media cannot provide.

Contact Us Today

Email -
Tel: +44-2036120886

Email -
Tel: +91 44 64536444

Our highly researched conference agenda delivers all the latest information and our world-class speakers attract delegates from around the world to attend. We aim for our attendees to be equipped with knowledge of latest developments and enable them to network with the industry key personnel.

What is the format of our conference programme?
The conference programme consists of world-class keynote addresses, case study presentations and panel discussions.

What are the benefits of attending?

  • Meet your peers in an interactive, discussion-based format designed to maximize knowledge transfer and networking
  • Enjoy our informal networking at drinks and lunch
  • Meet the leading solution providers in the market to forge partnerships and discover solutions
  • Receive electronic versions of the conference documentation for use of reference post-event.
  • Get ideas for?training topics?that you might want to present as professional development sessions to others in your workplace.
  • Observe speakers from the perspective of seeing what works really well so you can learn new public speaking techniques and strategies that you can apply when doing your own presentations.
  • Learn what not to do in presentations if you end up sitting through any sessions that fail to be engaging or informative.
  • Delegates also benefit from discounted rates onfuture event attendance

For more information or to register at the event please contact us TODAY:

Contact Us Today

Email -
Tel: +44-2036120886

Email -
Tel: +91 44 64536444

Coming Soon...

“PV 2010 was an opportunity to identify future clients as well as competitors along with an excellent learning platform”

Dr. Jayasheel B. G.
Pharmaceutical Professional, Ecronacunova

"The conference was indeed a great experience.Both the presentations and the panel discussions/interactive sessions were very enlightening.I would surely like to attend the  May clinical trial conference. I congratulate Virtue Insight for organizing a very useful and interesting Conference."

Dr. Varsha Narayanan
Medical Department, Elder Pharmaceuticals

For access to the presentations for this conference, please email us at

You have been registered successfully!
Enter Password
Submit Close